Jagsonpal Pharma - Quaterly Results
Date: 29-10-2026
A fair growth of 9.28% in the revenue at Rs. 813.75 millions was reported in the September 2026 quarter as compared to Rs. 744.65 millions during year-ago period.A meek growth of 0.13% was reported for the quarter ended September 2026 to Rs. 125.90 millions from Rs. 125.74 millions.Operating Profit reported a sharp decline to 189.97 millions from 194.61 millions in the corresponding previous quarter.
| | Quarter ended | Year to Date | Year ended |
| | 202609 | 202509 | % Var | 202609 | 202509 | % Var | 202603 | 202503 | % Var |
| Sales | 813.75 | 744.65 | 9.28 | 1636.07 | 1500.77 | 9.02 | 2872.25 | 2687.16 | 6.89 |
| Other Income | 22.31 | 30.27 | -26.30 | 50.64 | 58.52 | -13.47 | 119.95 | 81.90 | 46.46 |
| PBIDT | 189.97 | 194.61 | -2.38 | 390.70 | 364.99 | 7.04 | 700.69 | 592.61 | 18.24 |
| Interest | 2.51 | 2.65 | -5.28 | 5.02 | 5.19 | -3.28 | 10.28 | 9.58 | 7.31 |
| PBDT | 185.11 | 191.96 | -3.57 | 383.33 | 359.80 | 6.54 | 669.62 | 779.90 | -14.14 |
| Depreciation | 16.83 | 23.86 | -29.46 | 38.25 | 47.39 | -19.29 | 94.44 | 81.31 | 16.15 |
| PBT | 168.28 | 168.10 | 0.11 | 345.08 | 312.41 | 10.46 | 575.18 | 698.59 | -17.67 |
| TAX | 42.38 | 42.36 | 0.05 | 87.29 | 78.72 | 10.89 | 144.36 | 144.98 | -0.43 |
| Deferred Tax | 2.47 | 4.29 | -42.42 | 5.60 | 8.94 | -37.36 | 12.49 | 9.26 | 34.88 |
| PAT | 125.90 | 125.74 | 0.13 | 257.79 | 233.69 | 10.31 | 430.82 | 553.61 | -22.18 |
| Equity | 133.27 | 133.27 | 0.00 | 133.27 | 133.27 | 0.00 | 133.93 | 132.80 | 0.85 |
| PBIDTM(%) | 23.35 | 26.13 | -10.67 | 23.88 | 24.32 | -1.81 | 24.40 | 22.05 | 10.62 |
